Article metrics

Download PDFPDF

740 A first-in-human trial of hSTC810 (anti-BTN1A1 Ab), a novel immune checkpoint with a mutually exclusive expression with PD-1/PD-L1, in patients with relapsed/refractory solid tumors
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to January 2024

AbstractFullPdf
Nov 2022231022
Dec 202214806
Jan 2023130013
Feb 20231294036
Mar 202311809
Apr 202311206
May 202310606
Jun 202378011
Jul 202362010
Aug 202354014
Sep 20234205
Oct 20236608
Nov 20234604
Dec 20237807
Jan 20245805
Total26230162